Maria Laura ‘Marila’ Gennaro, whose research focuses on diagnosing tuberculosis (TB) and the antibody response to the SARS-CoV-2 infection that causes COVID-19, has been recognized as an academic inventor making a tangible impact on quality of life, economic development and the welfare of society. The professor of medicine at Rutgers New Jersey Medical School and a professor of epidemiology at Rutgers School of Public Health, has been named a National Academy of Inventors Fellow, which is the highest professional distinction accorded solely to academic inventors.

“We are thrilled for Marila to receive this recognition for the research she has conducted and the innovations she has developed,” said Tatiana Litvin-Vechnyak, associate vice president of Innovation Ventures, part of Rutgers Office for Research. “For many years, Marila’s team has been working to advance discoveries around infectious disease and specifically tuberculosis that have been instrumental to improving diagnosis and treatments of TB. More recently, her research on the antibody response to COVID-19, alongside other Rutgers colleagues, continues to help us gain a better understanding of how to combat the disease.” To read the full story.